KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) Other Operating Expenses (2017 - 2026)

Guardant Health's Other Operating Expenses history spans 9 years, with the latest figure at $242.9 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 33.19% to $242.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $843.7 million, a 28.86% increase, with the full-year FY2025 number at $843.7 million, up 28.86% from a year prior.
  • Other Operating Expenses hit $242.9 million in Q4 2025 for Guardant Health, up from $221.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for GH hit a ceiling of $242.9 million in Q4 2025 and a floor of $63.1 million in Q1 2021.
  • Historically, Other Operating Expenses has averaged $143.8 million across 5 years, with a median of $128.9 million in 2022.
  • Biggest five-year swings in Other Operating Expenses: soared 75.11% in 2021 and later decreased 18.97% in 2024.
  • Tracing GH's Other Operating Expenses over 5 years: stood at $93.0 million in 2021, then skyrocketed by 38.19% to $128.5 million in 2022, then surged by 75.07% to $225.0 million in 2023, then dropped by 18.97% to $182.4 million in 2024, then surged by 33.19% to $242.9 million in 2025.
  • Business Quant data shows Other Operating Expenses for GH at $242.9 million in Q4 2025, $221.0 million in Q3 2025, and $200.8 million in Q2 2025.